partnershipBenevolentAI Ltd inks US$594m partnership...British drug discovery specialist BenevolentAI Ltd has licenced its end-to-end AI platform capabilities to Merck KGaA to deliver novel drug candidates for three targets in oncology, neurology and im … more ➔
FinancingAboleris Pharma bags €27.3m in Series A...Autoimmunity specialist AbolerIS Pharma will use a €27.3m Series A Financing to advance its first-in-class antibody inducing immune tolerance in rheumatoid arthritis into the clinic. more ➔
Novel FoodGerman company aims for the first EU appro...The Cultivated B ist the first company in the world to apply for EU-Novel-Food authorisation of a hotdog made from plant protein and cultivated muscle cells. more ➔
Alzheimer'sResearchers stop brain cell death in Alzhe...A Belgian-British research team has identified the human protein underlying necroptosis of human brain cells in Alzheimer’s mice and stopped cell death. more ➔
M&APierre Fabre Laboratories acquires Vertica...French pharma company Pierre Fabre Laboratories has baged Vertical Bio to push development of the companys NSCLC candidate. more ➔ C more ➔
FinancingBioLamina AB bags €19m funding for expan...French-US-based investment specialist Lauxera Capital Partners announced today that it has invested €17m in Swedish cell culture company BioLamina AB (BioLamina) more ➔
radiopharmaceuticalRadiotherapy R&D partnershipOrano Med SAS and Orbit Discovery Ltd announced a collaboration to develop Peptide Receptor Radionuclide Therapies for cancer cells and develop novel radiopharmaceuticals. more ➔
Tech transferBioInnovation Institute Boosts Six Life Sc...Non-profit foundation BioInnovation Institute (BII) has unveiled its latest commitment to driving innovation and growth within the life science sector. Six promising companies will receive crucial financial … more ➔
NGTMajority of EU agri-council supports NGT d...At a council meeting, a majority of EU agriculture ministers have supported the draft regulation on new genomic technologies (NGT) proposed by the EU Commission in early July. more ➔
New detection method for protein degraders German researchers have developed a new way to detect the about 300 cullin-RING ligases (CRLs) which specifically trigger destruction of specific proteins in the cell. more ➔